 Impaired renal function is associated with reduced responsiveness to clopidogrel. There are no studies which have shown a means by which to overcome platelet hyporesponsiveness in patients with chronic kidney disease CKD. The purpose of this study was to determine the functional impact of cilostazol in patients with CKD undergoing hemodialysis. 